Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor in CF with Splicing Mutations
NCT02934698Phase 3Completed
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ivacaftor in cystic fibrosis (CF), sponsored by Medical University of South Carolina. Started Nov 2016; status: completed.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02934698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934698.